Anders Berg Jørgensen

3.2k total citations · 3 hit papers
7 papers, 1.9k citations indexed

About

Anders Berg Jørgensen is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anders Berg Jørgensen has authored 7 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anders Berg Jørgensen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Cancer, Lipids, and Metabolism (1 paper). Anders Berg Jørgensen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Cancer, Lipids, and Metabolism (1 paper). Anders Berg Jørgensen collaborates with scholars based in Denmark. Anders Berg Jørgensen's co-authors include Børge G. Nordestgaard, Ruth Frikke‐Schmidt, Anne Tybjærg‐Hansen, Anette Varbo, Marianne Benn, Anders Sode West, Peer Grande and Palle Toft and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Anders Berg Jørgensen

7 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

2012 759 citations Anette Varbo, Marianne Benn et al. Journal of the American College of Cardiology profile →
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

2014 697 citations Anders Berg Jørgensen, Ruth Frikke‐Schmidt et al. New England Journal of Medicine profile →
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

2012 362 citations Anders Berg Jørgensen, Ruth Frikke‐Schmidt et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Berg Jørgensen Denmark	5	1.2k	1.1k	835	441	231	7	1.9k
Angelo B. Cefalù Italy	26	1.1k 1.0×	896 0.8×	864 1.0×	384 0.9×	370 1.6×	129	2.5k
Hardi Mundl United States	13	1.2k 1.0×	958 0.9×	687 0.8×	344 0.8×	356 1.5×	30	2.1k
Amanda J. Hooper Australia	26	1.5k 1.3×	740 0.7×	636 0.8×	432 1.0×	227 1.0×	107	2.3k
Amar A Sethi Denmark	20	833 0.7×	950 0.9×	550 0.7×	255 0.6×	140 0.6×	26	1.7k
Megan Mucksavage United States	4	1.1k 1.0×	1.0k 0.9×	434 0.5×	368 0.8×	226 1.0×	5	1.9k
Allan D. Sniderman Canada	17	805 0.7×	733 0.7×	400 0.5×	245 0.6×	247 1.1×	37	1.5k
Takamitsu Nakano Japan	23	848 0.7×	1.3k 1.2×	710 0.9×	546 1.2×	411 1.8×	50	2.2k
Megan F. Burke United States	7	915 0.8×	812 0.7×	350 0.4×	301 0.7×	190 0.8×	9	1.7k
A.H.M. Smelt Netherlands	23	819 0.7×	764 0.7×	445 0.5×	225 0.5×	302 1.3×	52	1.8k
Isabelle L. Ruel Canada	21	1.0k 0.9×	597 0.5×	328 0.4×	370 0.8×	134 0.6×	69	1.5k

Countries citing papers authored by Anders Berg Jørgensen

Since Specialization

Citations

This map shows the geographic impact of Anders Berg Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Berg Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Berg Jørgensen more than expected).

Fields of papers citing papers by Anders Berg Jørgensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Berg Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Berg Jørgensen. The network helps show where Anders Berg Jørgensen may publish in the future.

Co-authorship network of co-authors of Anders Berg Jørgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Berg Jørgensen. A scholar is included among the top collaborators of Anders Berg Jørgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Berg Jørgensen. Anders Berg Jørgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jørgensen, Anders Berg, Ruth Frikke‐Schmidt, Børge G. Nordestgaard, & Anne Tybjærg‐Hansen. (2016). Loss-of-function mutations in APOC3, remnant cholesterol, LDL cholesterol, and risk of ischemic vascular disease. Atherosclerosis. 252. e251–e252. 1 indexed citations

2.

Jørgensen, Anders Berg, Ruth Frikke‐Schmidt, Børge G. Nordestgaard, & Anne Tybjærg‐Hansen. (2014). Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease. New England Journal of Medicine. 371(1). 32–41. 697 indexed citations breakdown →

3.

Jørgensen, Anders Berg, Ruth Frikke‐Schmidt, & Børge G. Nordestgaard. (2014). Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease. Journal of Vascular Surgery. 60(4). 1096–1096. 23 indexed citations

4.

Jørgensen, Anders Berg, Ruth Frikke‐Schmidt, Børge G. Nordestgaard, & Anne Tybjærg‐Hansen. (2014). Loss-of-function mutations in APOC3 and reduced risk of ischemic vascular disease. Atherosclerosis. 235(2). e18–e18. 3 indexed citations

5.

Varbo, Anette, Marianne Benn, Anne Tybjærg‐Hansen, et al.. (2012). Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease. Journal of the American College of Cardiology. 61(4). 427–436. 759 indexed citations breakdown →

6.

Jørgensen, Anders Berg, Ruth Frikke‐Schmidt, Anders Sode West, et al.. (2012). Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. European Heart Journal. 34(24). 1826–1833. 362 indexed citations breakdown →

7.

Toft, Palle & Anders Berg Jørgensen. (1987). Continuous thoracic epidural analgesia for the control of pain in myocardial infarction. Intensive Care Medicine. 13(6). 388–9. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact